江苏正大丰海医药有限公司

Chinese pharmaceutical company in Dafeng district, Yancheng, Jiangsu, formed as a foreign-controlled joint venture between the Chia Tai (CP) Pharmaceutical Group of Thailand and Jiangsu Agricultural Reclamation Group, with roots going back to 1970. Integrates research, manufacturing and sales across drug formulations, foods for special medical purposes, active pharmaceutical ingredients and drug development, describes itself as a leader in new-generation carbohydrate infusions and helped draft the related Chinese national quality standards. Core products include Fenghaineng fructose injection, Ledu racecadotril granules and esomeprazole sodium for injection, and it has been recognised as a Jiangsu high-tech enterprise and a Yancheng top-100 company.